Your browser doesn't support javascript.
loading
Surgical Site Infections in Trauma Exploratory Laparotomies Preoperative Ceftriaxone and Metronidazole Versus Cefoxitin.
Reese, Miles W; Roess, Brendan J; Hepner, John M; Hogge, Raymond L; Rendel, Ricardo; Martyak, Michael T; Kabir, Ishraq K; Nguyen, Tuan M; Snyder, Kristen N; Heaton, Julia A.
Afiliación
  • Reese MW; Department of Surgery, Eastern Virginia Medical School, Norfolk, VA, USA.
  • Roess BJ; Department of Surgery, Eastern Virginia Medical School, Norfolk, VA, USA.
  • Hepner JM; Department of Surgery, Eastern Virginia Medical School, Norfolk, VA, USA.
  • Hogge RL; Department of Surgery, Eastern Virginia Medical School, Norfolk, VA, USA.
  • Rendel R; Department of Surgery, Eastern Virginia Medical School, Norfolk, VA, USA.
  • Martyak MT; Department of Surgery, Eastern Virginia Medical School, Norfolk, VA, USA.
  • Kabir IK; Department of Surgery, Eastern Virginia Medical School, Norfolk, VA, USA.
  • Nguyen TM; Department of Surgery, Eastern Virginia Medical School, Norfolk, VA, USA.
  • Snyder KN; Department of Surgery, Eastern Virginia Medical School, Norfolk, VA, USA.
  • Heaton JA; Department of Surgery, Eastern Virginia Medical School, Norfolk, VA, USA.
Am Surg ; 90(7): 1960-1962, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38537664
ABSTRACT
Surgical site infections (SSIs) remain a significant cause of morbidity and mortality in patients undergoing traumatic exploratory laparotomy. The goal of this study was to compare antibiotic usage and subsequent outcomes in patients undergoing traumatic exploratory laparotomy. A retrospective chart analysis and a chi-square test of independence were performed to examine the relation between preoperative cefoxitin versus ceftriaxone and metronidazole and the rate of SSI development. 323 patients were analyzed, 111 patients receiving cefoxitin and 212 patients receiving ceftriaxone and metronidazole. The proportion of patients who developed SSI was 16.2% for the cefoxitin group and 9.9% for the ceftriaxone and metronidazole group, X2 (1, N = 323) = 2.7, P = .098, thus displaying no statistical difference in the development of SSIs between patients in the cefoxitin group when compared to the ceftriaxone and metronidazole group.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infección de la Herida Quirúrgica / Ceftriaxona / Cefoxitina / Laparotomía / Metronidazol / Antibacterianos Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Am Surg Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infección de la Herida Quirúrgica / Ceftriaxona / Cefoxitina / Laparotomía / Metronidazol / Antibacterianos Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Am Surg Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
...